Cargando…
The management challenges of a case with Flupentixol‐induced neuroleptic malignant syndrome
BACKGROUND: Neuroleptic malignant syndrome (NMS) is a rare and life‐threatening reaction. The incidence rate of NMS has dropped because of the higher use of atypical antipsychotics, compared with the typical ones. The mortality rate in patients taking injectable antipsychotics has been also by 38%....
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10009412/ https://www.ncbi.nlm.nih.gov/pubmed/36585735 http://dx.doi.org/10.1002/npr2.12315 |